A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)
- Conditions
- Metastatic Prostate Cancer
- Registration Number
- NCT06566989
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Male
- Target Recruitment
- 8
Inclusion Criteria:<br><br> - Is a healthy male according to the assessment of the investigator<br><br> - Has a body mass index of 18.0 to 32.0 kg/m2<br><br> - Has regular bowel movements (i.e., average stool production of =1 and =3 stools per<br> day)<br><br>Exclusion Criteria:<br><br> - Has the presence or history of clinically significant allergy requiring treatment<br><br> - Has a history of adrenal insufficiency<br><br> - Has veins not suitable for multiple venipunctures/cannulation<br><br> - Has previously taken part in more than 3 radiolabeled drug studies in the last 12<br> months<br><br> - Has donated blood or plasma within the previous 3 months or lost greater than 400 mL<br> of blood
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method